Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
156.97
+0.74 (+0.47%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
8
Next >
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
March 19, 2024
Balancing Dividends and Fundamentals: The Case of QUEST DIAGNOSTICS INC (NYSE:DGX).
Via
Chartmill
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
March 18, 2024
Benzinga used Public.com's bond screener tool to identify some of the highest-yielding investment-grade corporate bonds.
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
(DGX) - Analyzing Quest Diagnostics's Short Interest
March 05, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
February 27, 2024
Balancing Dividends and Fundamentals: The Case of QUEST DIAGNOSTICS INC (NYSE:DGX).
Via
Chartmill
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
February 26, 2024
Via
Benzinga
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
February 07, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Is NYSE:DGX suited for dividend investing?
February 05, 2024
Analyzing QUEST DIAGNOSTICS INC (NYSE:DGX)'s Dividend Potential.
Via
Chartmill
Beyond The Numbers: 7 Analysts Discuss Quest Diagnostics Stock
February 02, 2024
Via
Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on...
Via
Benzinga
Earnings Outlook For Quest Diagnostics
January 31, 2024
Via
Benzinga
Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points
February 01, 2024
The CNN Money Fear and Greed index showed a sharp decline in the overall market sentiment, while the index remained in the "Greed" zone on Wednesday.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 01, 2024
Quest Diagnostics Incorporated (NYSE: DGX) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 1, 2024.
Via
Benzinga
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
January 18, 2024
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.
Via
InvestorPlace
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection.
Via
Benzinga
Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement
January 02, 2024
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as disclosed in federal court papers filed in San Francisco.
Via
Benzinga
Expert Ratings for Quest Diagnostics
December 07, 2023
Via
Benzinga
Expert Ratings for Quest Diagnostics
November 17, 2023
Via
Benzinga
Quest Diagnostics Gains Momentum: Analyst Highlights Strong Business Trends And Growth Opportunities
December 20, 2023
Truist Securities analyst David S.
Via
Benzinga
Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement
December 13, 2023
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.
Via
Benzinga
Exposures
Product Safety
Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight
December 04, 2023
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
November 21, 2023
Explore the dichotomy in the latest S&P 500 rally: Strong overall performance masks the underperformance of nearly half its stocks.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Firing on All Cylinders Indeed
November 11, 2023
Investors are seeing some big reactions to earnings results in tech and have a few reasons to think some beaten-up names might be finding their footing.
Via
The Motley Fool
Quest Diagnostics Q3: 7.7% Topline Decline, Earnings Beat, Updated Guidance & More
October 24, 2023
Quest Diagnostics Incorporated (NYSE: DGX) posted Q3 FY23 adjusted EPS of $2.22, down 5.9% Y/Y, beating the
Via
Benzinga
Topics
Earnings
Exposures
Financial
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are...
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
3 Pharma Stocks to Buy as Summer COVID Cases Spike
August 23, 2023
Covid cases are on the rise, which might be the booster shot these top pharma stocks for Covid need to regain their trajectory.
Via
InvestorPlace
Exposures
COVID-19
Why Bionano Genomics Stock Tanked Today
August 14, 2023
A CFO departure shines a light on some of the company's recent struggles.
Via
The Motley Fool
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
August 09, 2023
Alzheimer's is a huge problem, and earlier detection could make a big difference.
Via
The Motley Fool
Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023
August 02, 2023
Investors looking for bargain stock opportunities in a rapidly-rising market should consider these companies that haven't yet bounced back.
Via
InvestorPlace
Quest Diagnostics Stock Falls on Lower Q2 Revenue and Profits from Lower Productivity Effects, Tightened Outlook
July 26, 2023
Quest Diagnostics Inc (NYSE: DGX) posted Q2 FY23 adjusted EPS of $2.30, down 2.5% Y/Y, beating the consensus of $2.27.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.